ARK Next Generation Internet ETF vs Neurocrine Biosciences Inc — how do they compare? ARK Next Generation Internet ETF trades at $150.93, while Neurocrine Biosciences Inc trades at $155.3 (market cap $16.46B). Which is the better fit depends on your goals.
| ARKW | NBIX | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $182.20 | $185.50 |
52-Week Low | $114.45 | $123.10 |
Market Cap | — | $16.46B |
Enterprise Value | — | $16.48B |
Trailing returns across standard periods
Latest headlines on both assets
ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.
Read more on ARKW →Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →